Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FGY25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,798
Award facts
- Contract value 100% obligated
- $15,798.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $15.8K to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 ml vials. The contract, which became effective on May 12, 2025, with an ultimate completion date of May 13, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location in Conshohocken, PA 19428. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.9M and extending through December 2026.
XGEVA is a prescription medication primarily used in oncology and bone health management. Through its substantial DLA IDC, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Department of Defense healthcare system, supplying an extensive portfolio of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FGY25?
SPE2DB25FGY25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FGY25 worth?
The government has obligated $15,798 on SPE2DB25FGY25.
Is contract SPE2DB25FGY25 an order under another contract?
Yes. SPE2DB25FGY25 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGY25 competed?
The extent of competition for SPE2DB25FGY25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award